NEW YORK, April 01, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that c...
Edison Pharmaceuticals Competitors or Alternatives
Edison Pharmaceuticals's top competitors include Pacira, Ashford Pain and Novus Spine & Pain Center.
Edison Pharmaceuticals VS Pacira
Pacira is one of Edison Pharmaceuticals's top competitors. Pacira is a Public company that was founded in Tampa, Florida in 2006. Pacira is in the Pharmaceuticals field. Pacira has 625 more employees vs. Edison Pharmaceuticals.
Edison Pharmaceuticals VS Ashford Pain
Ashford Pain is perceived as one of Edison Pharmaceuticals's biggest rivals. Ashford Pain was founded in 2021 in Athens, Georgia. Ashford Pain competes in the Health Care Services industry. Ashford Pain generates $31.5M less revenue than Edison Pharmaceuticals.
Edison Pharmaceuticals VS Novus Spine & Pain Center
Novus Spine & Pain Center is a top competitor of Edison Pharmaceuticals. Novus Spine & Pain Center's headquarters is in Lakeland, Florida, and was founded in 2016. Novus Spine & Pain Center competes in the Health Care Services field. Novus Spine & Pain Center generates 3.08% of Edison Pharmaceuticals's revenue.
Looking for similar companies to Edison Pharmaceuticals?
Similar Companies
Pharmaceuticals companies in Mountain View
See 17 companies
Companies in Mountain View with revenue in $25-100M rangeSee 371 companies
Pharmaceuticals & Biotechnology companies in Mountain ViewSee 58 companies
Health Care Equipment & Services companies in Mountain ViewSee 271 companies
Biotechnology companies in Mountain ViewSee 41 companies
Pharmaceuticals companies in San Francisco Bay AreaSee 512 companies
Pharmaceuticals companies with revenue in $25-100M rangeSee 827 companies
Biotechnology companies with revenue in $25-100M rangeSee 854 companies
Biotechnology companies in San Francisco Bay AreaSee 1,319 companies
Trending News for Edison Pharmaceuticals and Edison Pharmaceuticals's Competitors
Medtronic has issued a recall for several aortic root cannula devices due to a potential safety risk that could cause loose material to dislodge during...
Positive results from the PURSUIT phase IIb trial for AstraZeneca's AZD0780 demonstrated a statistically significant low─density lipoprotein cholestero...
The FDA on Thursday approved Amgen's rare disease drug Uplizna in an autoimmune disorder, setting the stage for the therapy to gain a foothold in the r...
The scholarship program is dedicated to developing the next generation of skilled trade workers. ROSEMEAD, Calif.-(BUSINESS WIRE)-Edison International ...
HTF MI just released the Global ICU Ventilator Market Study, a comprehensive analysis of the market that spans more than 143+ pages and describes the p...
VANCOUVER, BC / ACCESS Newswire / April 3, 2025 / Onco-Innovations Limited (CSE:ONCO)(OTCQB:ONNVF)(Frankfurt:W1H, WKN: A3EKSZ) ("Onco" or the "Company"...
read more...
EDISON INTERNATIONAL (EIX) Corporate Structure and Profiles Financial Highlights Dividend History Preference and Preferred Stock Five-Year Long-Term De...
The Global Acute Renal Failure Market reached US$ 5.30 million in 2023 and is expected to reach US$ 11.02 million by 2031, growing at a CAGR of 9.0% du...
Frequently Asked Questions about Edison Pharmaceuticals
Who are Edison Pharmaceuticals's top competitors?
Edison Pharmaceuticals's top 3 competitors are Pacira, Ashford Pain, Novus Spine & Pain Center.Who is similar to Edison Pharmaceuticals?
Pacira is the most similar to Edison Pharmaceuticals. Ashford Pain and Novus Spine & Pain Center are also similar to Edison Pharmaceuticals.
Are Edison Pharmaceuticals and Pacira competitors?
Yes, Pacira is one of Edison Pharmaceuticals’s top competitors.